As demonstrated by the clinical model (Table 4), the association between GLS and MACE remained significant (p = 0.003) after adjustment for clinical determinants of MACE (age, hypertension, diabetes, number of diseased vessels, peak hs-cTnT). This evidence concerns the gene TNNT2 and hypertensive disorder.